Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2026-01-10 @ 3:31 PM
Study NCT ID:
NCT03247556
Status:
COMPLETED
Last Update Posted:
2021-07-02
First Post:
2017-08-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD
Sponsor:
Supernus Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-20
Start Date Type:
ACTUAL
Primary Completion Date:
2019-02-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02-14
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-09
First Submit QC Date:
None
Study First Post Date:
2017-08-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-06-02
Results First Submit QC Date:
None
Results First Post Date:
2021-07-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-07-02
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-06-30
Last Update Post Date:
2021-07-02
Last Update Post Date Type:
ACTUAL